Search research articles
Contact Us
Filters
Showing results (41-50 of 79) with videos related to
Page
of 8
Sort By:
Frontiers in Oncology
|
May 31, 2021
Influence of Urethra Sparing on Tumor Control Probability and Normal Tissue Complication Probability in Focal Dose Escalated Hypofractionated Radiotherapy: A Planning Study Based on Histopathology Reference
Simon K B Spohn, Ilias Sachpazidis, Rolf Wiehle, et al.
Physics and Imaging in Radiation Oncology
|
April 10, 2026
Periodic intrafraction image-guided focal dose-escalated stereotactic body radiotherapy for prostate carcinoma on a standard linear accelerator
Marco Serpa, Rolf Wiehle, Thomas Rothe, et al.
Frontiers in Oncology
|
June 24, 2022
Risk Factors for Biochemical Recurrence After PSMA-PET-Guided Definitive Radiotherapy in Patients With <i>De Novo</i> Lymph Node-Positive Prostate Cancer
Simon K B Spohn, Viktoria Birkenmaier, Juri Ruf, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 10, 2025
A prospective study of immune responses in patients with lung metastases treated with stereotactic body radiotherapy with or without concurrent systemic treatment
Eleni Gkika, Elke Firat, Sonja Adebahr, et al.
Frontiers in Oncology
|
December 28, 2020
Comparison of Manual and Semi-Automatic [<sup>18</sup>F]PSMA-1007 PET Based Contouring Techniques for Intraprostatic Tumor Delineation in Patients With Primary Prostate Cancer and Validation With Histopathology as Standard of Reference
Simon K B Spohn, Maria Kramer, Selina Kiefer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
May 3, 2021
Intraoperative radiotherapy boost as part of breast-conservation therapy for breast cancer: a single-institution retrospective analysis
Raluca Stoian, Thalia Erbes, Constantinos Zamboglou, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 26, 2022
PSMA-PET- and MRI-Based Focal Dose Escalated Radiation Therapy of Primary Prostate Cancer: Planned Safety Analysis of a Nonrandomized 2-Armed Phase 2 Trial (ARO2020-01)
Constantinos Zamboglou, Simon K B Spohn, Juri Ruf, et al.
Scientific Reports
|
March 13, 2021
The impact of the co-registration technique and analysis methodology in comparison studies between advanced imaging modalities and whole-mount-histology reference in primary prostate cancer
Constantinos Zamboglou, Maria Kramer, Selina Kiefer, et al.
Computers in Biology and Medicine
|
April 24, 2025
A framework to create, evaluate and select synthetic datasets for survival prediction in oncology
A T Christoforou, S K B Spohn, T Sprave, et al.
Theranostics
|
April 22, 2024
Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [<sup>177</sup>Lu]Lu-PSMA-617 for prostate cancer - from bench to bedside
Daria Arbuznikova, Aikaterini Klotsotyra, Lisa Uhlmann, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 79) with videos related to
Sort By:
Page
of 8
Frontiers in Oncology
|
May 31, 2021
Influence of Urethra Sparing on Tumor Control Probability and Normal Tissue Complication Probability in Focal Dose Escalated Hypofractionated Radiotherapy: A Planning Study Based on Histopathology Reference
Simon K B Spohn, Ilias Sachpazidis, Rolf Wiehle, et al.
Physics and Imaging in Radiation Oncology
|
April 10, 2026
Periodic intrafraction image-guided focal dose-escalated stereotactic body radiotherapy for prostate carcinoma on a standard linear accelerator
Marco Serpa, Rolf Wiehle, Thomas Rothe, et al.
Frontiers in Oncology
|
June 24, 2022
Risk Factors for Biochemical Recurrence After PSMA-PET-Guided Definitive Radiotherapy in Patients With <i>De Novo</i> Lymph Node-Positive Prostate Cancer
Simon K B Spohn, Viktoria Birkenmaier, Juri Ruf, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 10, 2025
A prospective study of immune responses in patients with lung metastases treated with stereotactic body radiotherapy with or without concurrent systemic treatment
Eleni Gkika, Elke Firat, Sonja Adebahr, et al.
Frontiers in Oncology
|
December 28, 2020
Comparison of Manual and Semi-Automatic [<sup>18</sup>F]PSMA-1007 PET Based Contouring Techniques for Intraprostatic Tumor Delineation in Patients With Primary Prostate Cancer and Validation With Histopathology as Standard of Reference
Simon K B Spohn, Maria Kramer, Selina Kiefer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
May 3, 2021
Intraoperative radiotherapy boost as part of breast-conservation therapy for breast cancer: a single-institution retrospective analysis
Raluca Stoian, Thalia Erbes, Constantinos Zamboglou, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 26, 2022
PSMA-PET- and MRI-Based Focal Dose Escalated Radiation Therapy of Primary Prostate Cancer: Planned Safety Analysis of a Nonrandomized 2-Armed Phase 2 Trial (ARO2020-01)
Constantinos Zamboglou, Simon K B Spohn, Juri Ruf, et al.
Scientific Reports
|
March 13, 2021
The impact of the co-registration technique and analysis methodology in comparison studies between advanced imaging modalities and whole-mount-histology reference in primary prostate cancer
Constantinos Zamboglou, Maria Kramer, Selina Kiefer, et al.
Computers in Biology and Medicine
|
April 24, 2025
A framework to create, evaluate and select synthetic datasets for survival prediction in oncology
A T Christoforou, S K B Spohn, T Sprave, et al.
Theranostics
|
April 22, 2024
Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [<sup>177</sup>Lu]Lu-PSMA-617 for prostate cancer - from bench to bedside
Daria Arbuznikova, Aikaterini Klotsotyra, Lisa Uhlmann, et al.
Page
of 8